Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oncolytic activity of HF10 in head and neck squamous cell carcinomas.
Esaki S, Goshima F, Ozaki H, Takano G, Hatano Y, Kawakita D, Ijichi K, Watanabe T, Sato Y, Murata T, Iwata H, Shibamoto Y, Murakami S, Nishiyama Y, Kimura H. Esaki S, et al. Among authors: takano g. Cancer Gene Ther. 2020 Aug;27(7-8):585-598. doi: 10.1038/s41417-019-0129-3. Epub 2019 Sep 3. Cancer Gene Ther. 2020. PMID: 31477804 Free PMC article.
Long-term efficacy of weekly paclitaxel therapy in unresectable primary squamous cell carcinoma of the thyroid.
Iwaki S, Kawakita D, Sawabe M, Matoba T, Takano G, Oguri K, Murashima A, Minohara K, Tanaka N, Tsuge H, Imaizumi S, Matsumura A, Masaki A, Murase T, Ogawa M, Iwasaki S. Iwaki S, et al. Among authors: takano g. Auris Nasus Larynx. 2022 Dec;49(6):1083-1087. doi: 10.1016/j.anl.2021.06.005. Epub 2021 Jul 3. Auris Nasus Larynx. 2022. PMID: 34226099
Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab.
Minohara K, Matoba T, Kawakita D, Takano G, Oguri K, Murashima A, Nakai K, Iwaki S, Hojo W, Matsumura A, Ozaki S, Ozawa T, Harata I, Tanaka N, Maseki S, Tsuge H, Imaizumi S, Mitsuya S, Moribe K, Esaki S, Iwasaki S. Minohara K, et al. Among authors: takano g. Sci Rep. 2021 Aug 20;11(1):16992. doi: 10.1038/s41598-021-96538-7. Sci Rep. 2021. PMID: 34417539 Free PMC article.
Impact of tumor burden on survival in patients with recurrent or metastatic head and neck cancer treated with immune checkpoint inhibitors.
Matoba T, Minohara K, Kawakita D, Takano G, Oguri K, Murashima A, Nakai K, Iwaki S, Tsuge H, Tanaka N, Imaizumi S, Hojo W, Matsumura A, Tsukamoto K, Esaki S, Iwasaki S. Matoba T, et al. Among authors: takano g. Sci Rep. 2022 Aug 22;12(1):14319. doi: 10.1038/s41598-022-18611-z. Sci Rep. 2022. PMID: 35996017 Free PMC article.
Impact of age for overall survival in head and neck sarcoma.
Suzuki H, Takano G, Tsukushi S, Ando M, Yatabe Y, Kodaira T, Nishikawa D, Beppu S, Hasegawa Y, Hanai N. Suzuki H, et al. Among authors: takano g. Medicine (Baltimore). 2023 Feb 17;102(7):e32966. doi: 10.1097/MD.0000000000032966. Medicine (Baltimore). 2023. PMID: 36800630 Free PMC article.
Predictive factors for dissection-free sentinel node micrometastases in early oral squamous cell carcinoma.
Matsuzuka T, Tsukahara K, Yoshimoto S, Chikamatsu K, Shiotani A, Oze I, Murakami Y, Shinozaki T, Enoki Y, Ohba S, Kawakita D, Hanai N, Koide Y, Sawabe M, Nakata Y, Fukuda Y, Nishikawa D, Takano G, Kimura T, Oguri K, Hirakawa H, Hasegawa Y. Matsuzuka T, et al. Among authors: takano g. Sci Rep. 2023 Apr 15;13(1):6188. doi: 10.1038/s41598-023-33218-8. Sci Rep. 2023. PMID: 37061623 Free PMC article.
36 results